Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosis.
AD-214（一种用于治疗特发性肺纤维化的抗CXCR4 i-body-Fc融合蛋白）的开发和表征
期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2025.2505090
Lynch Jason P, Organ Louise, Tomusange Khamis, Kowalczyk Lukasz, Hartman Dallas J, Tester Angus, Hosking Chris, Foley Michael
